Clinical trial
Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis
NCT02952079 is registered in ClinicalTrials.gov with University of the Incarnate Word as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis
- Lead sponsor
- University of the Incarnate Word
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- April 30, 2018
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry eye, meibomian gland dysfunction, posterior blepharitis